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ABSTRACT 
This paper reviews common research methods which have been used in alternative medicine. 
We focus on a case series method called the before-after treatment experimental design. How 
this method can be used by practitioners to measure the effectiveness of their treatments is 
explored in depth. We address what variables should be measured before, during and after 
treatment. References to commonly used measurement instruments for physical, emotional and 
spiritually based variables are included. 
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INTRODUCTION 
As claims of treatment success in health care become more and more accountable, all who offer health-related treatments are being asked for proof that they are effective. There are several methods of research 
which can be used to gather data relevant to energy medicine 
treatments/outcomes. The focus of this paper is on methods measuring 
outcomes which can be used involving before-after treatment assessments of 
symptom frequency and severity, and physiological, psychological and spiritual 
factors. Variables such as quality of life, length of time the treatment effect 
lasts, and whether the treatment effects the amount of money spent on other 
health care resources are all important aspects of assessing these therapies. 
Assuming changes in these variables occur, how can you tell if the changes are 
significant and meaningful? 
Americans are turning to alternative medicine in large numbers. About 34% 
of the u.s. population utilized the services of alternative practitioners for an 
estimated 425 million visits during 1990 at a cost of over 10 billion dollars.1 
The report to the NIH "Expanding Medical Horizons" of March, 1995 has 
called for the establishment of alternative medicine research centers.2 Despite 
the broad use of alternative medicine treatments, there is a paucity of data 
available to demonstrate convincingly whether these AM practices are effica­
cious, safe, and/or beneficial. In addition we need to know more about whether 
alternative medicine practices lead to positive clinical outcomes, improve quality 
of life, reduce or eliminate adverse symptoms, prevent disease, or promote or 
enhance health. 
In a 1990 report released by the U. S. Office of Technology Assessment, 
essentially the same conclusion was drawn concerning the evaluation of 
unconventional cancer treatments.3 Joel Elkes believes that within 25 years 
mind-body techniques will permeate medical practice from primary care to 
specialty care.4 Arnold Relman, former editor of the New England Journal of 
Medicine, says that this may be possible but only if we can get more scientific 
evidence.4 Marcia Angell, Executive Editor of the New England Journal of 
Medicine remains skeptical about much of the research in alternative treatments, 
because many of the studies have been poorly designed and "characterized by 
exuberant interpretation."4 
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To be fair, the quality of research in conventional medicine is not stellar. The 
validity of all but about 30% of the claims in conventional medicine is question­
9able.5- Clearly the fact that there is copious but often faulty research in 
conventional medicine and scarcer but equally faulty research in alternative 
medicine doesn't give anyone much of a right to throw stones from their glass 
houses. 
This paper is a review of certain research methods that have been used in both 
conventional and alternative medicine, and of critiques which have been done 
suggesting the best ways of using these methods. For practitioners using 
methods new to the conventional field, a primary way to proceed is to gather 
more data on the methods by measuring multiple factors before and after 
treatment on a group of subjects where each subject serves as his or her own 
control. This is research that any practitioner can do in his or her own office 
or clinic. Grad pointed out that there is much anecdotal data on the success 
of healers. 10 He says that hard data is scarce, not because the process itself is 
that hard to investigate, but because those in the best position to evaluate the 
results of treatments have little interest in doing so. This paper is an attempt 
to generate some interest. 
SURVEY OF RESEARCH METHODS USEFUL IN 
ALTERNATIVE MEDICINE EVALUATION. 
Isaac and Michael 11 listed models of research methods and we have adapted 
their list to describe types of methods useful in alternative medicine research: 
Descriptive Studies. Both population studies such as Eisenberg, et. at. 1 which 
evaluated the incidence of alternative medicine utilization, and anecdotal case 
studies are descriptive studies. They simply describe what happened before, 
during and after the treatment, or present facts as reported by informants. 
Case Studies. The systematic study of whether treatments are effective begins 
at the level of the systematic case study. Articles by Green and Shellenberger, 12 
Benor,13 and Fahrion 14 contain excellent descriptions of how individual case 
studies should be done in order to provide evidence of treatment effects. 
Fahrion'sl5 case study of a woman with polycystic kidneys and post cancer 
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surgery abdominal pain provides an excellent example of the use of EEG 
measurement techniques comparing the brain waves of the healer and healee 
and a discussion of the types of data analyses which can legitimately be used 
in single case studies. There is a book devoted to single case study design 
authored by Barlow and Herson. 16 In situations where the signs or symptoms 
being monitored come and go rapidly with an effective treatment and the 
subject is willing for the investigator to temporarily withdraw treatment or 
substitute a less effective treatment for the one under study, a true random­
ized, cross-over, experimental trial can be done. These are called N = 1 random­
ized controlled trials and can turn what is otherwise only a case study into a 
trial with more robust design. I? 
I n any case, what distinguishes a useless or misleading anecdote from a valuable and interesting case report is the detail and relevance of the information reported. The more specific, detailed, and objective the 
information, the more useful it will be to those who read it. This informa­
tion should be such that someone reading it could reproduce the procedure 
and select a similar patient to the one treated. Sufficient information about 
other prognostic factors that could possibly influence the outcome need to be 
provided so that the reader can be confident that the outcome reported was 
not due to these factors. This requires considerable knowledge about what 
prognostic factors can influence the outcome. This information usually needs 
to be collected at the time of the treatment. The National Cancer Institute's 
"Best Case Series Guidelines" (reprinted and updated in the OAM report)2 is 
an example of standards for reporting on cases for cancer therapy. Similar 
guidelines are needed for other common illnesses. 
There is a type of case series study which is more powerfully persuasive than 
a single case study, uses statistical analysis, and can be feasibly done by the 
actual practitioner doing the treatments. This is called the before-after 
treatment experimental design. This method involves a series of before and 
after treatment measurements on many variables, the analysis of which attempts 
to show changes in a group of patients all receiving the same type of treatment. 
This design is essentially a series of single case srudies added together to form 
a group of patients whose data are pooled and statistically analyzed. Although 
this design avoids the ethical problem of assigning patients to a no treatment 
control group, there are problems with this design as far as scientific accept-
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22ability is concerned. 18- The main problem with the before-after treatment 
study is that it can overestimate, commonly by as much as 40%, the true effect 
of the treatment. It is difficult to be sure that the difference between the before 
and after treatment measures is due to the treatment alone, rather than to some 
other intervening variable which could account for the change. For example, 
if a patient scored high on a depression scale before treatment, fell in love 
during treatment, and scored low on depression after treatment, it could well 
be that falling in love was the change agent and not your treatment. 
Presumably, if you randomized patients to a no treatment control group who 
scored high on depression, just as many of them would fall in love and truly 
improve their depression as would those in your treatment group. Thus, the 
treatment effect is less likely to be over inflated when you compare the changes 
after treatment with the changes in a control group. 
However, since the before-after method remains the most practical one for a practitioner to use to generate data on his or her treatments, and forms the basis for data collection even in trials with control groups, 
it will be the main subject of this paper. If done properly, before-after studies 
even without control groups play an important part in the acquisition of 
scientific knowledge. In addition to using the measurement methods described 
in this paper, conclusions from these types of studies can be strengthened by 
having a clear hypothesis, careful planning for the analysis before the data is 
collected, and articulation of reasonable grounds as to why the results might 
apply beyond the group studied.23 
Correlational methods are used in test construction and in factor analytic 
studies which attempt to shorten existing questionnaires. Perhaps the best 
examples of such studies in behavioral medicine involve the Hopkins Symptom 
Checklist, which. when factor analyzed, became the Brief Symptom I nventory, 24 
and the General Well Being Scale recently factor analyzed by Levin. 25 Both of 
these scales are useful instruments for the clinician doing research in alterna­
tive medicine. Correlational methods are also used for evaluating associations 
between variables that may be causal, such as the strong and consistent relation­
ship between smoking and disease and the recently summarized association 
between religious and spiritual life and health.26 
Quasi experimental techniques include controlled studies where the control 
groups are not randomized. Control groups are groups which are as like the 
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treatment groups as possible, but they receive no treatment, standard treatment, 
or sham treatment. They may not take all the tests the treatment group takes 
during the same time span the patients take them. If the control group data 
is not collected at the same time as the treatment group it is called a histor­
ical control group. This type of comparison has considerable limitations and 
may provide erroneous conclusions.27 
True experimental studies are those which have random assignment of subjects 
to control and treatment groups. This type of study has been used in a number 
of alternative and complementary practices. These types of studies often include 
blinding to control for expectation effects and observer bias. The utility of 
blinding has been useful primarily in studies of the effectiveness of homeopathic 
dilutions.28-3o and herbalism.31 It has also been used in evaluating acupunc­
ture,30 although the issue of the appropriateness of some types of blinding and 
control groups when studying acupuncture treatments has been addressed by 
de La Torre.22 Benor's book18 contains a review of the controlled studies of 
healing, including randomized controlled studies. Oleson and Flocc032 
described a randomized controlled study of PMS with a reflexology based 
treatment which was successful in alleviating PMS symptoms. The use of the 
term "true experimental studies" by Isaacsll in describing this type of research 
reflects the paradigm bias typical of conventional medicine researchers. This 
type of design is most useful for simple and well defined diseases where short 
term treatment and outcomes are the main interest. It is less useful for making 
definitive conclusions about treatment for chronic illness. Many thought 
provoking papers exist questioning whether the old paradigm is actually a "true" 
one for evaluating some alternative medicine approaches. 18-22 The utility of 
"true experimental studies" is especially questionable when intentionality and 
expectation effects are used as a prime component of therapy and individual­
ization, learning, and choice are considered necessary for maximum benefit. 
Meta Analysis Research. A type of research not discussed by Isaacs, but 
nonetheless important is meta-analysis. This approach frames the integration 
of research data from comparable studies as a research effort in its own 
right.33,34 Meta analysis makes it possible to estimate the overall strength of 
a treatment's effectiveness across many experimental studies. The most compre­
hensive meta analysis of psychological, educational and behavioral treatments 
is that of Lipsey and Wilson.35 It includes some studies in biofeedback, medita-
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tion and relaxation techniques, which are often considered alternative 
treatments. Sacks7 provides an excellent analysis of how to do good research in 
meta analysis of randomized controlled studies in medicine, while concluding 
that only 30% of published meta analyses in medicine address all necessary 
issues for good research. Lipsey and Wilson35 conclude that any study which 
has a control group is an eligible study for meta analysis whether it is random­
ized or not. However, they looked only at behavioral and psychological 
treatments. 
There are a few meta analyses to date in alternative medicine. Some of them 
examine the effects of transcendental meditation, one on physiology,36 another 
on self actualization and psychological health,37 and one on trait anxiety.38 
Recently, Linde,39 looking at laboratory studies and Reilly,40 looking at clinical 
studies of immunotherapy have conducted meta analyses in homeopathic areas. 
Meta-analyses of manipulative therapy for low back pain,41 acupuncture for 
pain42,43 and addiction44 and the effectiveness of several herbal and nutritional 
therapies have also been done.45-47 Finally, there have been a number of meta 
analyses of experiments in parapsychology that, presumably, form the theoret­
ical foundation of therapies involving consciousness and subtle energies.48-50 
The main reason that there are so few meta analyses of research in alternative 
medicine is that there are so few studies which are comparable enough with 
one another that their subjects can be, in effect, added together. 
Qualitative Research. Many methodologist and researchers have discussed the 
problems in the old paradigm which have been used to evaluate both conven­
tional medicine and alternative medicine. 19-21 ,30,51-53 Researchers in the field 
of nursing and primary medical care are using new paradigms combining 
quantitative and qualitative methods of gathering data, using grounded theory 
research methods and hermeneutic analyses. Perhaps the best introduction 
to these important new paradigm shifting methodologies is Nursing Practice 
Research, a volume of the journal Advances in Nursing Science.54 Although 
qualitative methods have traditionally been used in anthropology and during 
the definition phase of a developing clinical research agenda, recent efforts 
have focused on the importance of grounding even long accepted outcomes 
by using qualitative methods, especially when conducting research in new 
populations.55,56 
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CONDUCTING PRACTICE BASED RESEARCH 
For the practitioner in his or her own office, however, the most practical way to demonstrate treatment effectiveness on a group of patients will be to use existing outcome measures in a before-after treatment design. 
The remainder of this paper will address variables that need to be measured 
and some of the existing ways to measure these variables. 
We would like to describe examples of how we thought about these and other 
questions when data was gathered in the biofeedback program at the Universiry 
of Colorado, Boulder, where Carol Schneider was once director of a biofeed­
back treatment clinic in the health service. In 1978, all the practitioners in the 
biofeedback clinic began to collect systematic data on every student who came 
for biofeedback. All of the instruments we used in the study are contained in 
the textbook Foundations of Clinical Biofeedback Practice. 57 We thought there 
would be changes in physical and emotional symptoms, feelings of well being, 
attitudes about self empowerment, and the physiologic parameters of muscle 
tension, hand temperature and galvanic skin response (a measure of autonomic 
nervous system arousal). We also thought the symptom changes and feelings 
about self empowerment would be long lasting. So we measured all those things 
on all our patients before and after treatment and then also sent a follow-up 
questionnaire to those we could track down after 6 months. 
Three years after we first began collecting the data, we decided to pick out 4 
different conditions (irritable bowel syndrome, anxiery, hypertension, and 
muscle contraction headache). We took the data from ten (10) randomly 
selected patients in each category and analyzed for before and after treatment 
effects on all the variables we measured. We decided on 10 patients in each 
group because we expected a large effect size, so we could use a relatively small 
group to demonstrate an effect. If you anticipate a small, but meaningful, 
effect, it is necessary to use larger groups. The sample size needed to 
demonstrate the effect you predict your treatment will have can be calculated 
mathematically by your research consultant. In order to do this you will need 
to estimate about how large an effect you expect. We presented our data at a 
symposium at the annual meeting of the Biofeedback Sociery of America.58 
The results were very positive in all four groups we studied and the follow up 
data showed lasting effects. Within a year researchers in other universities got 
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their graduate students busy doing controlled studies using many of our 
methods of treatment and measuring insttuments. They were studying the same 
variables we did with comparisons to control groups and getting results which 
were acceptable in the scientific world. As practicing therapists in a regular 
clinic setting, routinely gathering data of interest to us, we really made a contri­
bution to research in biofeedback, just by showing that the treatment had a 
meaningful effect which could be measured by simple measuring insttuments 
in an everyday clinical setting. 
BEFORE AND AFTER TREATMENT MEASUREMENTS 
A n important question to consider when gathering data is what variables will change as a result of the treatment, (e.g., physical, emotional and spiritual variables). The outcomes selected for measurement depend 
on the goals of treatment. These goals, whether explicit or not, are an 
agreement berween the practitioner and patient. There are basically four 
categories of outcomes that can be evaluated. One can look for cure (elimina­
tion of the sign, symptom or disease), care (better control or management of 
the magnitude or consequence of a symptom or illness), empowerment (better 
understanding of the meaning of the experience of illness and increased skills 
for self care and coping with illness and suffering), or enlightenment (realiza­
tion of the value and purpose of one's life as it is). Those in the mainstream 
medical community and most patients are usually looking for outcomes in the 
first rwo areas. Many alternative and healing practices and increasing numbers 
of patients are looking for outcomes in the second rwo areas. These objectives 
need to be clear at the beginning of any research so that the desired and 
appropriate data are collected. 
Suppose you, as a practitioner, have decided that you want to duplicate what 
we did and gather data to demonstrate that your treatment is effective. 
ON WHOM SHOULD DATA BE GATHERED? 
If it is useful for your treatment goals, it makes sense to gather data on all 
patients you treat. For example in our program we routinely discussed the 
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results of the Brief Symptom Inventory24 and our Weekly Symptom Chart57 
with every patient we treated. If you gather data on all patients, you can easily 
study whatever subset of the whole group you wish by selecting various groups, 
as we did. Of course, if there is no purpose other than research for a specific 
problem for which you would use the data, you could select your measuring 
devices and then just administer the measurement instruments to that group 
you wish to study, (e.g. only tension headache patients). You should gather 
data on yourself with respect to the treatment of your research patients as well. 
Cooperstein59 discussed aspects of trans personal healers' experiences that 
contribute to the process of healing and he also suggests some variables of the 
healers' experience that might be productively studied. 
INFORMED CONSENT 
You should obtain an informed consent form from your patient before you gather 
any data which will be used for research purposes. Because a general model for 
such a form has not been published elsewhere, a model is included here. 
WHAT VARIABLES SHOULD I MEASURE? 
1. 	 Belief System. BenorI3, stressed the importance of measuring the 
belief system of everyone involved in your study. Ask yourself; "Do 
I believe my treatment will help this patient? Do I feel a loving 
connection with this patient?" Data to obtain from the patient 
include: "Does he or she believe you can help?" Jonas60 has pointed 
our that simply asking your patient about the credibility of your 
treatment may reduce the overall effectiveness considerably. This 
may be because asking about belief in whether a treatment is 
effective raises doubts about whether it might be effective or not. 
Credibility needs to be authentic. 
Other data which are crucial include diagnosis, history of the 
symptom/disease, prognosis, and baseline data on the 
symptom/disease and medication before treatment. 13,S7 
2. 	 Physical Symptoms. The most simple yet often used method of 
collecting symptoms is a visual analog scale, which is a 10 
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MODEL FOR INFORMED CONSENT FORM FOR PRIVATE PRACTITIONERS 
The questionnaires that you are filling out are part of an ongoing research effort 
in order to obtain scientific data about your symptoms and their treatment. 
If your responses are ever used for any presentation, the data will be presented 
as averages over a group ofpeople having similar symptoms and treatments. There 
is no possible way that anyone could identifY you as one of the group, so that 
the confidentiality of your answers will be preserved. Nothing about your 
individual treatment will ever be presented anywhere in any form without an 
additional permission signed by you for that purpose. 
If you have any questions about this study, please feel free to ask. You have a 
right to be fully informed. 
You have a right to refuse to participate in this study. If you do participate, you 
will be contributing to a scientific knowledge base for the field of alternative 
medical treatments. Your voluntary contribution is valuable. 
If you wish a copy of any papers using group data which result from this study, 
they will be sent to you upon request. 
Witnessed by: (witness can be the research clinician) 
Date__________ 
centimeter line used especially for measuring the intensity of a 




no pain most intense 
pain experienced 
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The difference in the number of centimeters before and after 
treatment is considered a measurement of change in pain levels. A 
more complex symptom rating method which gives an average daily 
pain raring and can be plotted on a daily or weekly basis throughout 
treatment was used in the study mentioned above. 57 Since feelings 
of well being are not always correlated with symptom frequency and 
intensity, we added a 5 point well being scale and asked patients to 
rate both symptoms and well being every day. 
Whatever symptom measurement scale is used, the patient should 
rate the presence and severity of the symptom(s) for each of the 
7 days before treatment begins, even if done retrospectively. This 
is called baseline data and is a before treatment measurement. 
3. 	 Emotional States. If you think your treatments will produce an 
emotional effect as well as a physical one, you need to measure mood 
states before and after treatment. 
The most simple measurement device for emotional states is called 
the mood thermometer. A five item mood thermometer scale is 
discussed in Measures for Clinical Practice.61 This book contains 
over 300 clinical measuring scales presented by problem area and in 
their entirety along with one page profiles. Two other books which 
give profiles of tests in general use are guides from the Educational 
Testing Service62 and the Test Corporation of America.63 
Four more complex emotional scales which are in common use in 
current research done by clinical practitioners are the Brief Symptom 
Inventory,24,62,63 the Profile of Mood States,62.65 the Beck 
Depression Scale,62,63 and the General Well Being Scale.25 
There are several books which discuss the concepts and tests used 
71specifically to measure health and/or well being.66. These texts 
include information on many scales and techniques not discussed in 
this paper. The Bush Quality of Well Being Scale, formerly the 
Index of Well Being is widely used in nursing research and is worth 
investigation.72 
4. 	 Quality of Life. Like well being, some aspects of quality of life can 
improve even if symptoms do not. Included in qualiry of life 
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measurements are such factors as symptom improvement, pain 
management and stabilization, ability to take care of oneself indepen­
dently, lowered emotional distress, higher satisfaction with life, 
lowered alienation and enhanced social adjustment, improved coping 
with stress, increased activity levels, better ability to work produc­
tively, and enhanced self-efficacy and empowerment. Patrick has 
discussed the concept of quality of life in detail,73 as have Walker 
and Rosser,7o who include a very simple thermometer-like scale for 
measuring the different factors involvedJo (p,4ll) 
Developing reliable and valid outcome measures can be a complex 
task and it is probably best for a practitioner interested in research 
to use measures that are already established and extensively used for 
the areas of interest. One of the most extensively validated and 
easily used global measures of outcome is the SF 36, developed from 
work done by the RAND corporation. It involves 36 questions in 
7 domains of health and function. It can be filled out by the patient, 
usually in less than 10 minutes before a visit. Including a properly 
developed and widely used outcome measure such as the SF 36 may 
allow for comparison of your outcomes with complementary or 
conventional treatments in other settingsJ4 Wilkin and colleagues 
have written a dear and comprehensive description of common 
validated outcome measures, both global and condition specific and 
outlined their development, use and sources.75 
5. 	 Severity of Illness. While measuring oU[comes III practice can 
provide data on the effectiveness of your treatments, comparison 
with other practices requires not only standardized outcomes but 
comparable populations being treated. If the patients that you treat 
are either more or less ill than those you may want to compare them 
with, the outcomes may be different because of this difference in 
starting points. While direct comparisons of balanced groups of 
patients is the best way to make judgements about the relative effects 
of therapies, one can make some assessments of comparability if 
information on the severiry of illness groups is available. While 
responses on some oU[come measures (such as the SF 36 mentioned 
above) may indicate severity of impairment, a separate severity of 
illness assessment at the first visit may be usefuJ.76 If this is not 
possible, consider measuring the patients baseline more than once 
before treatment starts (separated by a reasonable period) to 
document the stability of his or her condition. 
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6. 	 Health Behaviors. Kaplan77,78 has made a case that changes in 
health related behaviors are actually the central variable in whether 
treatments are effective for making long term contributions to health 
and well being. Such factors as sleep, alcohol consumption, 
smoking, diet and social support are important to consider if 
improved health is a desired treatment outcome. 
7. 	 Self Actualizing Values. Crumbaugh79,80 has constructed two 
interesting tests, based on Viktor Frankl's work and an existential 
framework. The Purpose in Life Test has 30 items and measures 
the degree to which a person has found meaning and purpose in 
life, and the Seeking of Noetic Goals test, has 30 items which 
indicate how much interest the person has in doing so.80 
Shostrim's81 Personal Orientation Inventory shows the degree to 
which the respondent's attitudes and values compare with those of 
self actualizing people. Elmer Green has used this instrument in 
studying the healers in his Copper Wall Experiment and Patricia 
Norris uses it in her clinical practice for both teaching and research 
purposes. Changes in the direction of becoming more self actual­
izing would be a treatment goal many alternative practitioners might 
support. 
8. 	 Spirituality. The 3 Volume set, The Faith Factor: An Annotated 
Bibliography ofClinical Research on Spiritual Subjects, reviews research 
on spirituality.82 Levins3 has described research measuring religiosity 
and it's correlation with health. Ellison and Paloutzian84 have 
designed a questionnaire measuring spiritual well being which is 
widely used for this purpose. 
Most of the spiritually oriented work is heavily steeped in Judeo­
Christian traditional views. Some variables which would be 
important to consider are awareness of a higher self, experiencing a 
sense of connection to the ultimate energy source, having a concept 
of the oneness of all beings, an awareness of the power of the self 
to heal, belief in the power of prayer to heal, and having the ability 
to give and receive love. For now, the alternative practitioner could 
write descriptive statements and scale them in a 7 point Likert type 
scale from strongly agree to strongly disagree. Until a more general 
measure is developed for spirituality such a self made measure can 
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begin to assess this important variable with statements the practi­
tioner considers meaningful. Eventually some researcher will 
replicate, validate and factor analyze your questionnaire, but 
meanwhile you would have made a start on measuring the spiritual 
variables you consider important. 
9. 	 Physiological Measurements. Three main physiological measure­
ments have been used to demonstrate body-centered effects which 
are correlated with effective treatments. 
A. 	 Beta Endorphin levels. Peniston and Kulkosky,85 have 
demonstrated a change in the beta endorphin levels 
comparing before and after levels using an EEG based 
biofeedback treatment for drug and alcohol abusers. Beta 
endorphin is a hormone which is associated with levels of 
anxiery and agitation . 
B. 	 Immune Competence. Hall86 has reviewed the research 
in voluntary immunomodulation through relaxation and 
imagery therapy and he discusses the most useful immune 
measures to use. Anderson,87 reviewed the studies in 
immune competence improvements with behavioral 
treatments and Kiecolt-Glaser and Glaser review the 
methodological issues in such research. 88 
C. 	 EEG, EMG, and Temperature Readings Using 
Biofeedback Instruments. There is increasing use of 
before and after physiological measurements in the field of 
alternative medicine. Fahrion,15 has been a leader in using 
EEG in alternative medicine and Ed Wilson received the 
ISSSEEM annual award for excellence in energy medicine 
in 1993 primarily for his work with the EEG correspon­
dences between healers and healees and his studies of EEG 
before and during transcendental states of consciousness. 89 
Hall86 reviewed the work with GSR measurements and 
Wirth and Cram,90 have used EMG (muscle) data to 
measure the physiological effects of distant prayer. For the 
practicing clinician the least expensive of all physiological 
measurements are simple hand and foot temperature 
devices. The hand temperature of most human beings will 
show an increase when any treatment which purports to 
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relax its recipient is used. Before and after treatment hand 
temperature measurements, coupled with self reports of 
relaxation are important indicators of treatment success in 
lowering physiological arousal. These devices can be used 
for home training involving any practice of relaxation 
between treatments. For less than $20 a digital tempera­
ture measuring and training device suitable for office or 
home training can be obtained (Biofeedback 302 from 
Human Systems, P. O. Box 93663, Pasadena, CA 91109). 
Visual feedback from a liquid crystal strip which costs less 
than $5 can also be used for home practice (Bio-temp 
Products, P.O. Box 90050. Indianapolis, IN., 46290). 
These inexpensive devices can also measure increased blood 
flow to any body part to which it is attached. Physiological 
change data before and after treatment is very convincing, 
as it is more objective than most measurements used in 
treatment evaluation. Of course, such changes may be 
only correlates of the treatment, not necessarily the cause 
of the improvement. 
10. 	 What are the possible goals my treatment could aim for and which 
measurements before and after treatment could demonstrate? To 
summarize, the following outcomes may be important and should be 
carefully considered for inclusion in measuring outcomes in your practice. 
I. Decrease in physical symptoms 
2. Improve pain management95 
3. Improve health behaviors77,78.96 
4. Improve compliance with medical treatment78,91.94 
5. Improve Quality of Life5,97 
6. Improve General Well-bein~5 
7. General Medical Outcomes¥4 
8. Improve Spiritual Well Being83•84 
9. Improve social support and adjustment98,104 
10. 	 Improve coping with stressl05·111 
11. 	 The development of Hardiness1l2,IB 
12. 	 Improve attitudes toward coping with the illness. 
13. 	 Change in hormonal regulation, immunocompetence or physiolog. 
ical arousaI88,89,100,101,1 f4 
14. 	 Improve Emotional FunctioningllS.1l7 
15. 	 Decrease medical interventions needed for the illness (physician 
visits, medication. hospitalizations)1l8 
16. 	 Increase longevity64,99 
17. 	 Increase understanding of the meaning of the illness. 
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11. 	 What if my method requires that I use different treatments on each 
patient? Since at this point, you are just hoping to demonstrate that 
your treatments will have any effect, and not trying to demonstrate 
the mechanism by which these effects occur, you can use your usual 
treatment even if it's tailored to each patient's needs. If you are 
seeking to demonstrate mechanisms it is important to standardize 
what is done. If you limit your goals (and claims) to only showing 
that an important effect is occurring with your treatment, this 
approach is sufficient, especially if some corroborating objective 
physiological measurement is associated with clinical outcomes. 
MEASUREMENTS DURING TREATMENT 
Symptom/condition data should be gathered on a daily to weekly basis during treatment. Daily or weekly progress ratings can be usefup7 Many studies stop measuring weekly progress after treatment stops, but 
healers have noted that changes continue to occur after treatment is finished, 
so keep on measuring progress as long as you predict it will occur. Compliance 
94with any home training or associated treatment must be monitored. 91 - If 
you are teaching any skill as part of your treatment, you must demonstrate that 
that skill has been learned. 
At the conclusion of treatment, readminister all questionnaires given before 
treatment and measure again all physiological data. If you think your treatment 
effects will not be maximal until several days have passed after the actual session 
or sessions are completed, that is the point at which the readministration of 
all your outcome measuring data should occur. 
FOLLOW-UP DATA 
All physical, emotional, mental and spiritual measurements should be re 
administered either at 6 months or 1 year after treatment is finished. You 
should ask questions concerning any changes which have occurred since the 
treatment and whether they are related to the treatment, (e.g., changes in health 
related behaviors or reduction of stress). 
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• • • 
ANALYSIS OF YOUR DATA 
Research consultants include professors or graduate students at your local 
universities. The Office of Alternative Medicine is forming research centers 
where consultation on alternative medicine projects will be available.2 Two of 
these have now been funded. One at the Bastyr Naturopathic University 
focusing on AIDS, and one at the Minnesota Addiction dinic, looking at 
acupuncture and addiction. Others are being considered. ISSSEEM's publica­
tions will keep you updated on the activities of these centers, and provide 
information to you on where to get help with your project. By the time you 
have your data collected, help will be at hand. 
T o repeat, the main problem that this type of before and after treatment data presents is the overestimation of treatment effects. In fact, when control groups are added, the relative effect size will decrease by 40­
60%.60 A discussion of methodological and analysis errors which should be 
avoided in before-after treatment studies is contained in chapter 9 of Bjorn 
Andersen's book Methodological Errors in Medical Research. 5 Veney and 
Kalugneyl19 offer a very clear explanation of these before-after designs, their 
potential problems and simple statistics for evaluation of results. They 
recommend that these designs be widely used, as they are powerful enough to 
demonstrate results and to stimulate new controlled research projects. Two 
excellent books which discuss statistics for health professionals are available for 
those who wish to become more informed regarding methods of analysis. 120,121 
No doubt there are many areas that you, as alternative and complementary 
practitioners, will want to consider which haven't been mentioned in this paper. 
Let us know about your thoughts and concerns about important variables, 
topics, or anything else related to research. It is only by continued dialogue 
between researchers and practitioners that real advancement in the evaluation 
of these treatments will occur. 
CORRESPONDENCE: Carol J. Schneider, Ph.D. Colorado Center for Biobehavioral Health, 
939 Pearl Street • Boulder, CO 80302 
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